AI-generated summary
The authors developed an evidence-based clinical practice guideline on preventing oral mucositis in children receiving cancer treatment or stem cell transplantation. They reviewed randomised trials of cryotherapy, low level light therapy and keratinocyte growth factor. They suggest cryotherapy or low level light therapy may be offered to cooperative children, and keratinocyte growth factor with caution, all as weak recommendations.
- Who or what was studied
- Children aged 0 to 18 years receiving cancer treatment or haematopoietic stem cell transplantation
- Limits stated in the abstract
- All three recommendations are weak, there is a lack of efficacy and toxicity data for keratinocyte growth factor in children, and the abstract notes key research gaps.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spcare.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.